Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer: A Retrospective Multi-Site Assessment of Real-World Incidence, Risk-Factors, and Management Practices

被引:0
|
作者
Atchley, W. [1 ]
Alvarez, C. [2 ]
Saxena-Beem, S. [2 ]
Schwartz, T. A. [3 ]
Ishiziwar, R. C. [2 ]
Patel, K. P. [1 ]
Rivera, M. [1 ]
机构
[1] Univ N Carolina, Pulm & Crit Care, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Rheumatol Allergy & Immunol, Chapel Hill, NC 27515 USA
[3] Univ N Carolina, Biostat, Chapel Hill, NC 27515 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A6179
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Real-World Incidence, Risk Factors, and Management Practices Across Six Health Care Centers in North Carolina
    Atchley, William T.
    Alvarez, Carolina
    Saxena-Beem, Shruti
    Schwartz, Todd A.
    Ishizawar, Rumey C.
    Patel, Kunal P.
    Rivera, M. Patricia
    [J]. CHEST, 2021, 160 (02) : 731 - 742
  • [2] Incidence of Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer
    Poulose, Vijo
    [J]. CHEST, 2022, 161 (03) : E196 - E197
  • [3] Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China
    Shi, Yuequan
    Fang, Jian
    Zhou, Chengzhi
    Liu, Anwen
    Wang, Yan
    Meng, Qingwei
    Ding, Cuimin
    Ai, Bin
    Gu, Yangchun
    Yao, Yu
    Sun, Hong
    Guo, Hui
    Zhang, Cuiying
    Song, Xia
    Li, Junling
    Xu, Bei
    Han, Zhiqiang
    Song, Meijun
    Tang, Tingyu
    Chen, Peifeng
    Lu, Hongmin
    Shui, Yongjie
    Lou, Guangyuan
    Zhang, Dongming
    Liu, Jia
    Liu, Xiaoyan
    Liu, Xiangning
    Gao, Xiaoxing
    Zhou, Qing
    Chen, Minjiang
    Zhao, Jing
    Zhong, Wei
    Xu, Yan
    Wang, Mengzhao
    [J]. THORACIC CANCER, 2022, 13 (03) : 412 - 422
  • [4] Incidence of Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Response
    Atchley, William T.
    Rock, Little
    Alvarez, Carolina
    Saxena-Beem, Shruti
    Schwartz, Todd A.
    Ishizawar, Rumey C.
    Patel, Kunal P.
    Rivera, M. Patricia
    [J]. CHEST, 2022, 161 (03) : E197 - E197
  • [5] Risk Factors for Refractory Immune Checkpoint Inhibitor-related Pneumonitis in Patients With Lung Cancer
    Tan, Peixin
    Huang, Wei
    He, Xinyan
    Lv, Fengquan
    Cui, Yanhai
    Du, Shasha
    [J]. JOURNAL OF IMMUNOTHERAPY, 2023, 46 (02) : 64 - 73
  • [6] Rate and risk factors of recurrent immune checkpoint inhibitor-related pneumonitis in patients with lung cancer
    Tao, Haitao
    Li, Fangfang
    Wu, Dongxiao
    Ji, Shiyu
    Liu, Qingyan
    Wang, Lijie
    Liu, Bo
    Facchinetti, Francesco
    Leong, Tracy L.
    Passiglia, Francesco
    Hu, Yi
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (03) : 381 - +
  • [7] The Risk Factors Associated with Immune Checkpoint Inhibitor-Related Pneumonitis
    Asada, Mizuho
    Mikami, Takahisa
    Niimura, Takahiro
    Zamami, Yoshito
    Uesawa, Yoshihiro
    Chuma, Masayuki
    Ishizawa, Keisuke
    [J]. ONCOLOGY, 2021, 99 (04) : 256 - 259
  • [8] Checkpoint Inhibitor Pneumonitis - Real-World Incidence and Risk
    Tay, Rebecca Y.
    Califano, Raffaele
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : 1812 - 1814
  • [9] Risk factors for immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer
    Chao, Yencheng
    Zhou, Jiebai
    Hsu, Shujung
    Ding, Ning
    Li, Jiamin
    Zhang, Yong
    Xu, Xiaobo
    Tang, Xinjun
    Wei, Tianchang
    Zhu, Zhengfei
    Chu, Qian
    Neal, Joel W.
    Wu, Julie Tsu-Yu
    Song, Yuanlin
    Hu, Jie
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (02) : 295 - +
  • [10] Deep learning for predicting the risk of immune checkpoint inhibitor-related pneumonitis in lung cancer
    Cheng, M.
    Lin, R.
    Bai, N.
    Zhang, Y.
    Wang, H.
    Guo, M.
    Duan, X.
    Zheng, J.
    Qiu, Z.
    Zhao, Y.
    [J]. CLINICAL RADIOLOGY, 2023, 78 (05) : e377 - e385